Can I switch from Wellbutrin (bupropion) to Auvelity (dextromethorphan/bupropion) while on estradiol therapy and low‑dose doxepin?

Switching from Wellbutrin to Auvelity While on Estradiol and Low-Dose Doxepin

Yes, you can switch from Wellbutrin (bupropion) to Auvelity (dextromethorphan/bupropion), but be aware that Auvelity contains bupropion as one of its components, so you're not truly switching away from bupropion—you're adding dextromethorphan to your existing bupropion therapy. This combination may offer faster antidepressant effects, but requires careful consideration of your concurrent medications.

Understanding What Auvelity Is

Auvelity is FDA-approved for major depressive disorder and combines:

• Dextromethorphan 45 mg (NMDA receptor antagonist/sigma-1 receptor agonist)
• Bupropion 105 mg (which inhibits CYP2D6 to increase dextromethorphan levels) 1

The bupropion component serves dual purposes: it has antidepressant effects AND increases dextromethorphan bioavailability by blocking its metabolism 1.

Key Consideration: Estradiol Interaction

Critical concern: Estradiol therapy significantly inhibits CYP2B6, the enzyme responsible for metabolizing bupropion. Hormone replacement therapy reduces bupropion's hydroxylation by 49%, leading to 47% higher bupropion levels 2. This means:

• Your current Wellbutrin dose may already be producing higher-than-expected bupropion levels
• Switching to Auvelity (which contains 105 mg bupropion per tablet, twice daily = 210 mg/day) could result in excessive bupropion exposure
• Seizure risk increases with higher bupropion levels 3

Dosing Strategy with Estradiol

If you're currently on:

• Wellbutrin SR 150 mg twice daily (300 mg/day): Auvelity provides 210 mg/day bupropion, which may be appropriate given the estradiol interaction
• Wellbutrin XL 300 mg daily: Similar considerations apply
• Higher Wellbutrin doses (450 mg/day): Auvelity would represent a significant dose reduction

Monitor closely for:

• Dizziness, nausea, headache (most common Auvelity side effects) 4
• Seizure warning signs (bupropion lowers seizure threshold) 3
• Blood pressure and heart rate changes 5

Low-Dose Doxepin Compatibility

Low-dose doxepin (typically used for sleep/anxiety) does not have significant documented interactions with either bupropion or dextromethorphan. However:

• Doxepin may cause sedation; combined with dextromethorphan's somnolence risk, monitor for excessive drowsiness 4
• No contraindication exists for this combination

Clinical Evidence for Auvelity

Auvelity demonstrates faster onset than bupropion monotherapy:

• Significant improvement seen at week 1-2 versus 4-6 weeks for traditional antidepressants 6, 7
• Week 6 remission rates: 46.5% (Auvelity) vs 16.2% (bupropion alone) 7
• Mean MADRS score reduction: -17.3 points (Auvelity) vs -12.1 points (bupropion) at week 6 7

Switching Protocol

Direct switch approach (since Auvelity contains bupropion):

1. Stop your current Wellbutrin the evening before starting Auvelity
2. Start Auvelity the next morning:
   • Days 1-3: One tablet (45/105 mg) once daily in the morning
   • Day 4 onward: One tablet twice daily (morning and at least 8 hours later) 1
3. Do NOT overlap Wellbutrin and Auvelity—this would result in excessive bupropion dosing

Monitoring Requirements

• Week 1-2: Watch for dizziness, nausea, anxiety (most common early side effects) 4
• Ongoing: Blood pressure and heart rate checks (both medications can increase these) 5
• Seizure precautions: Avoid alcohol, maintain regular sleep, stay hydrated 3

Contraindications and Cautions

Absolute contraindications (do not use Auvelity if any apply):

• Seizure disorder history
• Eating disorder (anorexia/bulimia)
• Abrupt alcohol/benzodiazepine discontinuation
• MAOI use within 14 days 3

Relative cautions with your regimen:

• Estradiol increases bupropion levels—may need lower effective dose 2
• Monitor for serotonin syndrome if doxepin dose is higher (unlikely at low doses)

Expected Timeline

• Days 1-7: Tolerability assessment; side effects typically mild-to-moderate 6
• Week 1-2: Potential early antidepressant response (faster than traditional SSRIs) 7
• Week 6: Full therapeutic assessment 7

Common Pitfalls to Avoid

1. Do not take both Wellbutrin and Auvelity together—this doubles bupropion exposure
2. Do not crush or split Auvelity tablets—they are extended-release formulations 1
3. Space doses 8-12 hours apart—twice daily dosing required after day 3 1
4. Account for estradiol's effect—you may be more sensitive to bupropion's effects than typical patients 2

Bottom line: The switch is feasible and may offer faster antidepressant effects, but requires careful attention to the estradiol-bupropion interaction and seizure risk monitoring. Your prescriber should be aware of your hormone therapy when determining if Auvelity's bupropion content is appropriate for your situation.